Acquired factor XIII deficiency in patients under therapeutic plasma exchange: A poorly explored etiology

Acquired factor XIII deficiency in patients under therapeutic plasma exchange: A poorly explored etiology

Introduction Factor XIII (FXIII) deficiency may cause bleeding under certain clinical circumstances. Therapeutic plasma exchange (TPE) may lead to a transient deficiency. Objectives To describe the clinical evolution of patients with acquired FXIII deficiency secondary to TPE. Methods We respectivel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical apheresis 2021-02, Vol.36 (1), p.59-66
Hauptverfasser: Chuliber, Fernando Andrés, Penchasky, Diana, Santoro, Diego Mario, Viñuales, Susana, Otero, Victoria, Villagra Iturre, Maximiliano, Privitera, Verónica, Mezzarobba, Daniela, Burgos Pratx, Leandro, López, Marina Sol, Barrera, Luis, Schutz, Natalia, Arbelbide, Jorge, Martinuzzo, Marta
Format: Artikel
Sprache:eng
Schlagworte:
Apheresis
bleeding
factor XIII
factor XIII deficiency
Kidney transplants
Plasma
therapeutic plasma exchange
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Factor XIII (FXIII) deficiency may cause bleeding under certain clinical circumstances. Therapeutic plasma exchange (TPE) may lead to a transient deficiency. Objectives To describe the clinical evolution of patients with acquired FXIII deficiency secondary to TPE. Methods We respectively studied a cohort of consecutive patients from 2014 to 2019 who were treated with TPE with FXIII levels
ISSN:0733-2459
1098-1101
DOI:10.1002/jca.21840